Marc Rohrschneider

Head New Technologies, Device Development and Commercialisation
Company: 
Novartis AG

Marc holds a Master's degree in English and Biology from the Ruhr University in Bochum (Germany) and a Ph.D. in Pharmaceutical Technology from Heinrich Heine University in Düsseldorf (Germany).
He started his career in the pharmaceutical industry in 2001 in Germany, as Project Manager in Regulatory Affairs for Respimat® Soft Mist Inhaler at STEAG microParts GmbH. From 2004 to 2011, Marc held increasingly senior positions in the development of inhalation devices and formulations at Boehringer Ingelheim. In 2012, he joined the Biopharma division of Boehringer Ingelheim as Senior Manager, Technology and Innovation, before being appointed Head of Device Development and Combined Products for biopharmaceuticals in 2014. In July 2017, Marc joined Novartis Pharma AG as Head of New Technology, Device Development and Marketing within TRD.

Sessions: